Sequana Medical announces positive results for DSR 2.0 candidate
Extensive phase 1 clinical trial evaluates safety of treatment among peritoneal patients
Read More
Tag: DSR 2.0
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
